Inventor · disambiguated record
James Thomas Reuberson
Also filed as: REUBERSON JAMES · REUBERSON JAMES THOMAS
18 granted patents·13 pending applications·166 citations·filing 1996–2022
91Inventor score
Files withUCB BIOPHARMA SPRL14UCB Biopharma SRL7CELLTECH THERAPEUTICS LTD3UCB PHARMA SA2ASTRAZENECA AB1
Top patents by PatentIndex Score
31 records- 0193US5849770ATri-substituted phenyl derivatives useful as PDE IV inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1996·Granted Dec 15, 1998·141 cites·28 claims
- 0277US9550737B2TNF -α modulating benzimidazolesUCB BIOPHARMA SPRL·Filed 2013·Granted Jan 24, 2017·4 cites·10 claims
- 0376US10087180B2Pyrazolo-pyridine derivatives as kinase inhibitorsUCB BIOPHARMA SPRL·Filed 2015·Granted Oct 2, 2018·2 cites·12 claims
- 0475US9309243B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2013·Granted Apr 12, 2016·4 cites·11 claims
- 0571US9815797B2Fused bicyclic heteroaromatic derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Nov 14, 2017·2 cites·8 claims
- 0670US9227984B2Therapeutically active fused pyrimidine derivativesBROOKINGS DANIEL CHRISTOPHER·Filed 2012·Granted Jan 5, 2016·2 cites·11 claims
- 0770US9096614B2Therapeutically active thiazolo-pyrimidine derivativesUCB PHARMA SA·Filed 2012·Granted Aug 4, 2015·2 cites·10 claims
- 0868US10004737B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jun 26, 2018·1 cites·8 claims
- 0967US9969748B2Fused bicyclic heteroaromatic derivatives as kinase inhibitorsUCB BIOPHARMA SPRL·Filed 2015·Granted May 15, 2018·1 cites·12 claims
- 1060US7498338B2CompoundsASTRAZENECA AB·Filed 2004·Granted Mar 3, 2009·1 cites·11 claims
- 1155US2024294534A1Imidazotriazine derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 1252US2024140951A1Imidazopyridazine derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 1352US2009176815A1Novel Tricyclic Spiropiperidine Compounds, Their Synthesis and Their Uses as Modulators of Chemokine Receptor ActivityERIKSSON TOMAS·Filed 2009·Application pending·0 cites
- 1449US12391688B2Imidazopyridine derivatives as IL-17 modulatorsUCB Biopharma SRL·Filed 2020·Granted Aug 19, 2025·0 cites·10 claims
- 1548US2018201622A1Fused Bicyclic Heteroaromatic Derivatives as Kinase InhibitorsUCB BIOPHARMA SPRL·Filed 2018·Application pending·0 cites
- 1648US2023271951A1Difluorocyclohexyl derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 1747USRE48622ETherapeutically active pyrazolo-pyrimidine derivativesUCB BIOPHARMA SPRL·Filed 2019·Granted Jul 6, 2021·0 cites·12 claims
- 1846US2008167332A1Novel Compounds 243GIBSON SCOTT·Filed 2007·Application pending·0 cites
- 1945US11472794B2Fused imidazole derivatives as IL-17 modulatorsUCB Biopharma SRL·Filed 2019·Granted Oct 18, 2022·0 cites·12 claims
- 2045US2023399328A1Dicyclopropylmethyl derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 2144US6319922B1Propanoic acid derivativesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Nov 20, 2001·6 cites·15 claims
- 2244US2002035092A1Propanoic acid derivativesCELLTECH THERAPEUTICS LTD·Filed 2001·Application pending·0 cites
- 2343US2022242855A1Fused Imidazole Derivatives as IL-17 ModulatorsUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2442US9714248B2Therapeutically active pyrazolo-pyrimidine derivativesUCB PHARMA SA·Filed 2013·Granted Jul 25, 2017·0 cites·12 claims
- 2541US9382263B2Therapeutically active oxazoline derivativesUCB BIOPHARMA SPRL·Filed 2013·Granted Jul 5, 2016·0 cites·14 claims
- 2637US2018273525A1Fused Pyridine Derivatives As Kinase InhibitorsUCB BIOPHARMA SPRL·Filed 2016·Application pending·0 cites
- 2737US2018298009A1Fused Pyrazole Derivatives As Kinase InhibitorsUCB BIOPHARMA SPRL·Filed 2016·Application pending·0 cites
- 2836US10450320B2Hexahydropyrazinotriazinone derivatives as kinase inhibitorsUCB BIOPHARMA SPRL·Filed 2016·Granted Oct 22, 2019·0 cites·20 claims
- 2936US2018222868A1Indazole Derivatives as Modulators of TNF ActivityUCB BIOPHARMA SPRL·Filed 2016·Application pending·0 cites
- 3035US2002099210A1Propanoic acid derivatives as integrin inhibitorsFiled 2000·Application pending·0 cites
- 3132US10000497B2Fused bicyclic heteroaromatic derivatives as kinase inhibitorsUCB BIOPHARMA SPRL·Filed 2015·Granted Jun 19, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when James Thomas Reuberson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →